GlaxoSmithKline_NN
153_CD
Shareholder_NN
information_NOMZ
Ordinary_NN
shares_NN
Annual_JJ
General_NN
Meeting_VBG [WZPRES]
2003_CD
The_DT
company_NN
's_POS
shares_NN
are_VPRT [PASS]
listed_VBN
on_PIN
the_DT
London_NN
Stock_NN
Exchange_NN
._.
The_DT
Queen_NN
Elizabeth_NN
II_NN
Conference_NN
Centre_NN
,_,
19th_JJ
May_POMD
2003_CD
Broad_NN
Sanctuary_NN
,_,
Westminster_NN
,_,
Registrar_NN
London_NN
SW1P_NN
3EE_NN
The_DT
company_NN
's_POS
share_NN
register_NN
is_VPRT [BYPA]
administered_VBN
by_PIN
Lloyds_NN
TSB_NN
Registrars_NN
,_,
who_WP
also_RB
provide_VPRT
the_DT
following_JJ
services_NN
:_:
The_DT
Annual_JJ
General_NN
Meeting_VBG [WZPRES]
is_VPRT [BEMA]
the_DT
company_NN
's_POS
principal_JJ
forum_NN
for_PIN
communication_NOMZ
with_PIN
private_JJ
shareholders_NN
._.
In_CONJ
addition_NULL
to_PIN
the_DT
formal_JJ
GlaxoSmithKline_NN
Investment_NOMZ
Plan_NN
resolutions_NOMZ
to_TO
be_VB [PASS]
put_VBN
to_PIN
the_DT
meeting_GER
,_,
there_EX
will_PRMD
be_VB
a_DT
presentation_NOMZ
The_DT
plan_NN
enables_VPRT
shareholders_NN
to_TO
reinvest_VB
quarterly_JJ
dividends_NN
by_PIN
the_DT
Chief_NN
Executive_NN
Officer_NN
on_PIN
the_DT
performance_NN
of_PIN
the_DT
business_NOMZ
and_CC
or_CC
make_VB
monthly_JJ
investments_NOMZ
in_PIN
the_DT
company_NN
's_POS
ordinary_JJ
and_CC
its_PIT
future_JJ
development_NOMZ
._.
There_EX
will_PRMD
be_VB
opportunity_NOMZ
for_PIN
questions_NOMZ
shares_NN
using_VBG [WZPRES]
a_DT
special_JJ
dealing_GER
arrangement_NOMZ
._.
to_PIN
the_DT
Board_NN
,_,
and_ANDC
the_DT
Chairmen_NN
of_PIN
the_DT
Board_NN
's_POS
committees_NN
will_PRMD
GlaxoSmithKline_NN
Individual_NN
Savings_GER
Account_NN
take_VB
questions_NOMZ
on_PIN
matters_NN
relating_VBG [WZPRES]
to_PIN
those_DEMO
committees_NN
._.
The_DT
GlaxoSmithKline_NN
Individual_NN
Savings_GER
Account_NN
ISA_NN
is_VPRT [BEMA]
a_DT
Investors_NN
holding_VBG [PRIV] [WZPRES]
shares_NN
in_PIN
the_DT
company_NN
through_PIN
a_DT
nominee_NN
service_NN
tax-efficient_JJ
way_NN
to_TO
invest_VB
in_PIN
the_DT
company_NN
's_POS
ordinary_JJ
shares_NN
._.
should_NEMD
arrange_VB [SUAV]
with_PIN
that_DEMO
nominee_NN
service_NN
to_TO
be_VB [PASS]
appointed_VBN
as_IN
a_DT
GlaxoSmithKline_NN
Corporate_NN
Sponsored_NN
Nominee_NN
corporate_JJ
representative_NN
or_CC
proxy_NN
in_PIN
respect_NN
of_PIN
their_TPP3
shareholding_GER
The_DT
corporate_JJ
sponsored_VBN
nominee_NN
provides_VPRT
a_DT
facility_NOMZ
for_PIN
in_PIN
order_NN
to_TO
attend_VB
and_PHC
vote_VB [SUAV]
at_PIN
the_DT
meeting_GER
._.
shareholders_NN
to_TO
hold_VB [PRIV]
shares_NN
without_PIN
the_DT
need_NN
for_PIN
share_NN
ADR_NN
holders_NN
wishing_VBG [WZPRES]
to_TO
attend_VB
the_DT
meeting_GER
must_NEMD
obtain_VB
a_DT
proxy_NN
certificates_NN
._.
Shareholders_NN
'_POS
details_NN
will_PRMD
not_XX0
be_VB [PASS]
held_VBN [PRIV]
on_PIN
the_DT
main_JJ
from_PIN
The_DT
Bank_NN
of_PIN
New_NN
York_NN
which_WDT [WHSUB]
will_PRMD
enable_VB
them_TPP3
to_TO
attend_VB
the_DT
share_NN
register_NN
,_,
and_ANDC
so_RB
will_PRMD
remain_VB
confidential_JJ
._.
meeting_GER
and_PHC
vote_NN
on_PIN
the_DT
business_NOMZ
to_TO
be_VB [PASS]
transacted_VBN
._.
ADR_NN
holders_NN
Shareview_NN
service_NN
may_POMD
instruct_VB [SUAV]
The_DT
Bank_NN
of_PIN
New_NN
York_NN
as_IN
to_PIN
how_RB
the_DT
shares_NN
The_DT
shareview_NN
portfolio_NN
service_NN
provides_VPRT
shareholders_NN
with_PIN
represented_VBN
by_PIN
their_TPP3
ADRs_NN
should_NEMD
be_VB [BYPA]
voted_VBN [SUAV]
by_PIN
completing_VBG
and_CC
information_NOMZ
on_PIN
their_TPP3
investment_NOMZ
in_PIN
the_DT
company_NN
._.
Shareholders_NN
returning_VBG [WZPRES]
the_DT
voting_NN
card_NN
provided_VBN [WZPAST]
by_PIN
The_DT
Bank_NN
of_PIN
New_NN
York_NN
in_PIN
may_POMD
register_VB
for_PIN
this_DEMO
service_NN
at_PIN
www_NN
._.
accordance_NN
with_PIN
the_DT
instructions_NOMZ
given_VBN
._.
Share_NN
dealing_VBG [WZPRES]
facility_NOMZ
Financial_NN
reporting_VBG [PUBV] [WZPRES]
NatWest_NN
Stockbrokers_NN
Limited_JJ
offers_VPRT
a_DT
share-dealing_JJ
service_NN
on_PIN
Financial_NN
reporting_VBG [PUBV] [WZPRES]
calendar_NN
2003_CD
behalf_NN
of_PIN
the_DT
company_NN
to_PIN
shareholders_NN
wishing_VBG [WZPRES]
to_TO
buy_VB
or_CC
sell_VB
the_DT
Announcement_NOMZ
of_PIN
1st_CD
Quarter_NN
Results_NN
30th_JJ
April_NN
2003_CD
company_NN
's_POS
shares_NN
._.
Announcement_NOMZ
of_PIN
2nd_CD
Quarter_NN
Results_NN
23rd_JJ
July_NN
2003_CD
Share_NN
price_NN
information_NOMZ
Announcement_NOMZ
of_PIN
3rd_CD
Quarter_NN
Results_NN
22nd_JJ
October_NN
2003_CD
Share_NN
price_NN
information_NOMZ
is_VPRT [BEMA]
available_PRED
on_PIN
the_DT
company_NN
's_POS
website_NN
at_PIN
Preliminary_JJ
Announcement_NOMZ
of_PIN
Annual_JJ
Results_NN
12th_JJ
February_NN
2004_CD
www_NN
._.
Information_NOMZ
is_VPRT [BEMA]
also_RB
available_PRED
on_PIN
Ceefax_NN
,_,
Teletext_NN
,_,
Publication_NOMZ
of_PIN
Annual_JJ
Report_NN
Review_NN
March_NN
2004_CD
and_CC
from_PIN
FT_NN
Cityline_NN
by_PIN
calling_VBG
0906 003 5694_CD
or_CC
0906 843 5694_CD
calls_NN
charged_VBN [WZPAST]
at_PIN
60p_CD
a_DT
minute_NN
plus_PIN
VAT_NN
at_PIN
all_QUAN
times_NN
._.
Results_NN
Announcements_NOMZ
The_DT
Results_NN
Announcements_NOMZ
are_VPRT [PASS]
issued_VBN
to_PIN
the_DT
London_NN
Stock_NN
American_NN
Depositary_NN
Shares_NN
Exchange_NN
LSE_NN
,_,
and_ANDC
made_VBD
available_JJ
on_PIN
the_DT
LSE_NN
news_NN
service_NN
,_,
and_ANDC
The_DT
company_NN
's_POS
shares_NN
are_VPRT [PASS]
listed_VBN
on_PIN
the_DT
New_NN
York_NN
Stock_NN
Exchange_NN
at_PIN
the_DT
same_JJ
time_NN
,_,
or_CC
shortly_TIME
afterwards_TIME
,_,
are_VPRT [PASS]
issued_VBN
to_PIN
the_DT
media_NN
,_,
in_PIN
the_DT
form_NN
of_PIN
American_JJ
Depositary_NN
Shares_NN
ADSs_NN
and_CC
these_DEMP
are_VPRT
are_VPRT [PASS]
made_VBN
available_JJ
on_PIN
the_DT
website_NN
and_CC
are_VPRT [PASS]
filed_VBN
in_PIN
the_DT
USA_NN
with_PIN
evidenced_VBN
by_PIN
American_JJ
Depositary_NN
Receipts_NN
ADRs_NN
,_,
each_QUAN
one_CD
of_PIN
the_DT
Securities_NOMZ
and_PHC
Exchange_NN
Commission_NN
and_CC
the_DT
New_NN
York_NN
Stock_NN
which_WDT [WHSUB]
represents_VPRT
two_CD
ordinary_JJ
shares_NN
._.
ADR_NN
program_NN
administrator_NN
Financial_NN
reports_VPRT [PUBV]
The_DT
ADR_NN
program_NN
is_VPRT [BYPA]
administered_VBN
by_PIN
The_DT
Bank_NN
of_PIN
New_NN
York_NN
,_,
The_DT
company_NN
publishes_VPRT
an_DT
Annual_JJ
Report_NN
and_CC
,_,
for_PIN
the_DT
investor_NN
not_XX0
who_WP
also_RB
provide_VPRT
the_DT
following_VBG
service_NN
:_:
needing_VBG [PRESP]
the_DT
full_JJ
detail_NN
of_PIN
the_DT
Report_NN
,_,
an_DT
Annual_JJ
Review_NN
._.
These_DEMP
are_VPRT [BEMA]
Global_JJ
BuyDIRECT_NN
available_JJ
from_PIN
the_DT
date_NN
of_PIN
publication_NOMZ
on_PIN
the_DT
GlaxoSmithKline_NN
Global_NN
BuyDIRECT_NN
is_VPRT [BEMA]
a_DT
direct_JJ
ADS_NN
purchase_NN
sale_NN
and_PHC
dividend_NN
website_NN
._.
reinvestment_NOMZ
plan_NN
for_PIN
ADR_NN
holders_NN
._.
The_DT
Annual_JJ
Review_NN
is_VPRT [PASS]
sent_VBN
to_PIN
all_QUAN
shareholders_NN
on_PIN
the_DT
date_NN
of_PIN
publication_NOMZ
._.
Shareholders_NN
may_POMD
elect_VB
to_TO
receive_VB
also_RB
the_DT
Report_NN
by_PIN
Publications_NOMZ
writing_VBG [PUBV] [WZPRES]
to_PIN
the_DT
companys_NN
registrars_NN
._.
Alternatively_CONJ
shareholders_NN
may_POMD
elect_VB
to_TO
receive_VB
notification_NOMZ
by_PIN
email_NN
of_PIN
the_DT
publication_NOMZ
of_PIN
financial_JJ
This_DEMO
year_NN
GlaxoSmithKline_NN
has_VPRT [SPAU] [PEAS]
again_TIME
produced_VBN
a_DT
separate_JJ
report_NN
reports_NN
by_PIN
registering_VBG
on_PIN
www_NN
._.
covering_VBG [PRESP]
the_DT
Groups_NN
contribution_NOMZ
to_PIN
society_NN
._.
The_DT
2002_CD
Corporate_JJ
and_CC
Social_NN
Responsibility_NOMZ
Report_NN
covers_VPRT
the_DT
issues_NN
that_TSUB
are_VPRT [BEMA]
of_PIN
Copies_NN
of_PIN
previous_JJ
financial_JJ
reports_NN
are_VPRT [BEMA]
available_PRED
on_PIN
the_DT
company_NN
's_POS
primary_JJ
interest_NN
to_PIN
stakeholders_NN
,_,
including_VBG [PRESP]
the_DT
contribution_NOMZ
to_TO
website_VB
._.
Printed_NN
copies_NN
can_POMD
be_VB [PASS]
obtained_VBN
from_PIN
the_DT
registrar_NN
in_PIN
the_DT
society_NN
,_,
business_NOMZ
ethics_NN
and_PHC
integrity_NOMZ
,_,
access_NN
to_PIN
medicines_NN
,_,
R&D_NN
,_,
UK_NN
and_CC
from_PIN
the_DT
Customer_NN
Response_NN
Center_NN
in_PIN
the_DT
USA_NN
._.
community_NOMZ
investment_NOMZ
,_,
the_DT
environment_NOMZ
and_PHC
health_NN
and_PHC
safety_NN
._.
The_DT
report_NN
is_VPRT [BEMA]
available_PRED
from_PIN
the_DT
Secretariat_NN
at_PIN
the_DT
companys_NN
head_VPRT
office_NN
and_CC
the_DT
website_NN
at_PIN
www_NN
._.
